Product Description: HU 433 is a synthetic cannabinoid CB2 receptor agonist and is the enantiomer of HU 308 (HY-161510). HU 433 exerts its anti-inflammatory and neuroprotective effects by binding to CB2 receptors. HU 433 can be used in the study of neuroinflammation and retinal diseases[1].
Applications: COVID-19-immunoregulation
Formula: C27H42O3
References: [1]Young A P, et al. Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia In Vitro[J]. ACS Pharmacology & Translational Science, 2024.
CAS Number: 1220887-84-2
Molecular Weight: 414.62
Research Area: Inflammation/Immunology; Neurological Disease; Others